Coupling Krebs cycle metabolites to signalling in immunity and cancer.

TitleCoupling Krebs cycle metabolites to signalling in immunity and cancer.
Publication TypeJournal Article
Year of Publication2019
AuthorsRyan, DG, Murphy, MP, Frezza, C, Prag, HA, Chouchani, ET, O'Neill, LA, Mills, EL
JournalNat Metab
Date Published2019 Jan

Metabolic reprogramming has become a key focus for both immunologists and cancer biologists, with exciting advances providing new insights into underlying mechanisms of disease. Metabolites traditionally associated with bioenergetics or biosynthesis have been implicated in immunity and malignancy in transformed cells, with a particular focus on intermediates of the mitochondrial pathway known as the Krebs cycle. Among these, the intermediates succinate, fumarate, itaconate, 2-hydroxyglutarate isomers (D-2-hydroxyglutarate and L-2-hydroxyglutarate) and acetyl-CoA now have extensive evidence for "non-metabolic" signalling functions in both physiological immune contexts and in disease contexts, such as the initiation of carcinogenesis. This review will describe how metabolic reprogramming, with emphasis placed on these metabolites, leads to altered immune cell and transformed cell function. The latest findings are informative for new therapeutic approaches which could be transformative for a range of diseases.

Alternate JournalNat Metab
Citation Key10.1038/s42255-018-0014-7
PubMed ID31032474
PubMed Central IDPMC6485344
Grant ListMC_UU_12022/6 / / Medical Research Council / United Kingdom